Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Psychopathology
|
July 3, 2008
A comparison of life events in adolescents with major depression, borderline personality disorder and matched controls: a pilot study
Netta Horesh, Sharon Ratner, Nathaniel Laor, et al.
The Israel Journal of Psychiatry and Related Sciences
|
May 12, 2017
Assessing the Use of the Child Attachment Interview in a Sample of Israeli Jewish Children
Amit Baumel, Leo Wolmer, Nathaniel Laor, et al.
The Journal of Nervous and Mental Disease
|
July 16, 2025
Psychiatric Comorbidities in Fibromyalgia: A Comparison With Chronic Conditions and Healthy Controls
Chen Avni, Maya Morr, Dana Sinai, et al.
Drug Safety
|
November 24, 2004
Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents
Paz Toren, Sharon Ratner, Nathaniel Laor, et al.
Psychiatry Research
|
March 16, 2023
Discovering your presumed father is not your biological father: Psychiatric ramifications of independently uncovered non-paternity events resulting from direct-to-consumer DNA testing
Chen Avni, Dana Sinai, Uri Blasbalg, et al.
Journal of Child Sexual Abuse
|
March 3, 2016
Psychophysiological Reactivity in Child Sexual Abuse
Galit Ben-Amitay, Nir Kimchi, Leo Wolmer, et al.
Comprehensive Psychiatry
|
August 16, 2014
Impact of environmental and personality factors upon adolescents before and after psychotherapeutic intervention
Shlomit Mittler, Netta Horesh, Hilla Rubin Maytal, et al.
The Journal of Clinical Psychiatry
|
April 9, 2005
Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study
Paz Toren, Abraham Weizman, Sharon Ratner, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 22, 2005
Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder
Sharon Ratner, Nathaniel Laor, Yifat Bronstein, et al.
The American Journal of Psychiatry
|
March 4, 2006
A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders
Magali Reyes, Jan Buitelaar, Paz Toren, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Psychopathology
|
July 3, 2008
A comparison of life events in adolescents with major depression, borderline personality disorder and matched controls: a pilot study
Netta Horesh, Sharon Ratner, Nathaniel Laor, et al.
The Israel Journal of Psychiatry and Related Sciences
|
May 12, 2017
Assessing the Use of the Child Attachment Interview in a Sample of Israeli Jewish Children
Amit Baumel, Leo Wolmer, Nathaniel Laor, et al.
The Journal of Nervous and Mental Disease
|
July 16, 2025
Psychiatric Comorbidities in Fibromyalgia: A Comparison With Chronic Conditions and Healthy Controls
Chen Avni, Maya Morr, Dana Sinai, et al.
Drug Safety
|
November 24, 2004
Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents
Paz Toren, Sharon Ratner, Nathaniel Laor, et al.
Psychiatry Research
|
March 16, 2023
Discovering your presumed father is not your biological father: Psychiatric ramifications of independently uncovered non-paternity events resulting from direct-to-consumer DNA testing
Chen Avni, Dana Sinai, Uri Blasbalg, et al.
Journal of Child Sexual Abuse
|
March 3, 2016
Psychophysiological Reactivity in Child Sexual Abuse
Galit Ben-Amitay, Nir Kimchi, Leo Wolmer, et al.
Comprehensive Psychiatry
|
August 16, 2014
Impact of environmental and personality factors upon adolescents before and after psychotherapeutic intervention
Shlomit Mittler, Netta Horesh, Hilla Rubin Maytal, et al.
The Journal of Clinical Psychiatry
|
April 9, 2005
Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study
Paz Toren, Abraham Weizman, Sharon Ratner, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 22, 2005
Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder
Sharon Ratner, Nathaniel Laor, Yifat Bronstein, et al.
The American Journal of Psychiatry
|
March 4, 2006
A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders
Magali Reyes, Jan Buitelaar, Paz Toren, et al.
Page
of 4